Cargando…
Botulinum neurotoxin A ameliorates depressive-like behavior in a reserpine-induced Parkinson’s disease mouse model via suppressing hippocampal microglial engulfment and neuroinflammation
Depression is one of the common non-motor symptoms of Parkinson’s disease (PD). In the clinic, botulinum neurotoxin A (BoNT/A) has been used to treat depression. In this study, we investigated the mechanisms underlying the anti-depressive effect of BoNT/A in a PD mouse model. Mice were administered...
Autores principales: | Li, Yang, Yin, Qiao, Li, Qi, Huo, An-ran, Shen, Ting-ting, Cao, Jia-qian, Liu, Chun-feng, Liu, Tong, Luo, Wei-feng, Cong, Qi-fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310724/ https://www.ncbi.nlm.nih.gov/pubmed/36765267 http://dx.doi.org/10.1038/s41401-023-01058-x |
Ejemplares similares
-
Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons
por: Dong, Min, et al.
Publicado: (2007) -
Unilateral facial injection of Botulinum neurotoxin A attenuates bilateral trigeminal neuropathic pain and anxiety-like behaviors through inhibition of TLR2-mediated neuroinflammation in mice
por: Chen, Wei-Jia, et al.
Publicado: (2021) -
On Botulinum Neurotoxin Variability
por: Montecucco, Cesare, et al.
Publicado: (2015) -
Botulinum neurotoxin A modulates the axonal release of pathological tau in hippocampal neurons
por: Panzi, Chiara, et al.
Publicado: (2023) -
Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?
por: Poulain, Bernard, et al.
Publicado: (2019)